Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

Novo Nordisk Chief Executive Lars Jorgensen challenged Medicare's new role negotiating prescription drug prices during his testimony before a Senate committee on the company's blockbuster diabetes and ...

Looking at options history for Novo Nordisk NVO we detected 11 trades. If we consider the specifics of each trade, it is ...

A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...

WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo ...

The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs ...

In a landmark move, the FTC filed a lawsuit targeting the “Big Three” PBMs: CVS Health’s Caremark Rx, Cigna’s Express Scripts (ESI), and UnitedHealth Group’s OptumRx. The suit also includes their ...

Novo Nordisk CEO has cautioned that reducing drugs’ list prices can carry harmful unintended consequences for patients’ ...

U.S. Senator Bernie Sanders announced commitments from all major pharmacy benefit managers (PBMs) to expand coverage of Novo Nordisk's diabetes and weight-loss drugs, Ozempic and Wegovy, if the ...

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, faced tough questions on Capitol Hill Tuesday as lawmakers pressed the company ...

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its ...